1. Universal Sustained Viral Response to the Combination of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir with/without Ribavirin in Patients on Hemodialysis Infected with Hepatitis C Virus Genotypes 1 and 4
Abad et al. Am J Nephrol 2017;45:   (DOI: / )
Table 1. Baseline characteristics of the study population

2. Universal Sustained Viral Response to the Combination of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir with/without Ribavirin in Patients on Hemodialysis Infected with Hepatitis C Virus Genotypes 1 and 4
Abad et al. Am J Nephrol 2017;45:   (DOI: / )
Table 2. Laboratory values before and after treatment

3. Universal Sustained Viral Response to the Combination of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir with/without Ribavirin in Patients on Hemodialysis Infected with Hepatitis C Virus Genotypes 1 and 4
Abad et al. Am J Nephrol 2017;45:   (DOI: / )
Table 3. Adverse effects related to treatment